Overview
A coenzyme for a number of oxidative enzymes including NADH DEHYDROGENASE. It is the principal form in which RIBOFLAVIN is found in cells and tissues.
Indication
No indication information available.
Associated Conditions
- Iron Deficiency Anemia (IDA)
- Migraine
- Vitamin B complex deficiency
- Vitamin Deficiency
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2017/08/10 | Phase 4 | Completed | Comprehensive EyeCare of Central Ohio | ||
2009/02/11 | Phase 2 | UNKNOWN |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
No FDA approvals found for this drug. |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
SOLUVIT N FOR INFUSION | SIN05209P | INJECTION, POWDER, FOR SOLUTION | 4.9 mg/vial | 11/14/1990 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
SUPER B COMPLEX | sisu inc. | 00678996 | Capsule - Oral | 25 MG | 12/31/1986 |
DEFENSE CAPLETS | nu-life nutrition ltd. | 00863394 | Tablet - Oral | 25 MG | 8/15/1997 |
GTF SUPPORT CAPLET | nu-life nutrition ltd. | 01938436 | Tablet - Oral | 5 MG | 8/15/1997 |
DINOMALS | awareness corporation | 02237540 | Liquid - Oral | 1 MG / 10 ML | 2/10/2001 |
ACTI-HEMOSYN CAPLET | acti-form ltd. | 00899917 | Tablet - Oral | 2 MG | 12/31/1991 |
MULTI 1000 | 00586315 | Solution - Intravenous | 1 MG / ML | 12/31/1984 | |
FORMULA SF-710 | thorne research inc. | 00786500 | Capsule - Oral | 5 MG | 12/31/1991 |
SUPER B COMPLEX | nutri-cology | 00562882 | Capsule - Oral | 25 MG / CAP | 12/31/1982 |
NRG PLUS LIQ | jeunique international inc. | 02085593 | Liquid - Oral | 7.5 MG / 15 ML | 2/17/1998 |
MEDIPRO | thorne research inc. | 02231935 | Powder - Oral | 1 MG / 15 G | 9/9/1997 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
No CIMA AEMPS (Spain) approvals found for this drug. |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.